Engineered sequestrins inhibit aggregation of pathogenic alpha-synuclein mutants
{{output}}
Misfolding and aggregation of the neuronal protein alpha-synuclein (aSyn) has been identified as a hallmark of Parkinson's disease (PD) pathology and other synucleinopathies. Preventing formation of intracellular aSyn accumulations constitutes a therapeutic s... ...
